Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 116,079 189,843 233,203 571,547
Total Sell Value $10,217,149 $17,085,208 $20,986,230 $54,848,304
Total People Sold 5 5 6 7
Total Sell Transactions 11 17 23 53
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1303
  Page 30 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Mark VP, Human Resources   •       –      –    2011-02-22 4 S $26.34 $43,330 D/D (1,645) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-02-22 4 OE $14.39 $25,797 D/D 1,645 15,888     -
   Wood Mark VP, Human Resources   •       –      –    2011-02-01 4 S $26.00 $34,684 D/D (1,334) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-02-01 4 OE $14.39 $22,871 D/D 1,334 15,577     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-02-01 4 S $25.76 $21,462 D/D (833) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-02-01 4 OE $11.05 $9,205 D/D 833 31,833     -
   Wood Mark VP, Human Resources   •       –      –    2011-01-24 4 S $25.73 $24,138 D/D (938) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2011-01-24 4 OE $14.39 $13,498 D/D 938 15,181     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-01-18 4 AS $26.58 $93,030 D/D (3,500) 90,067     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-01-03 4 S $26.99 $22,485 D/D (833) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-01-03 4 OE $11.05 $9,205 D/D 833 31,833     -
   Wood Mark VP, Human Resources   •       –      –    2010-12-22 4 S $28.21 $69,940 D/D (2,479) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-12-22 4 OE $14.39 $40,425 D/D 2,479 16,722     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-12-20 4 S $28.00 $140,000 D/D (5,000) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-12-20 4 OE $11.05 $55,250 D/D 5,000 36,000     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-13 4 S $27.43 $27,429 D/D (1,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-13 4 OE $6.46 $6,460 D/D 1,000 94,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-06 4/A S $27.17 $54,348 D/D (2,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-06 4/A OE $6.46 $12,920 D/D 2,000 95,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-06 4 S $27.17 $27,174 D/D (1,000) 93,567     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-12-06 4 OE $6.46 $6,460 D/D 1,000 94,567     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-12-01 4 S $27.08 $22,587 D/D (834) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-12-01 4 OE $11.05 $9,216 D/D 834 31,834     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-11-24 4 S $27.50 $137,504 D/D (5,000) 27,901     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-11-24 4 OE $11.74 $58,700 D/D 5,000 32,901     -
  1303 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 30 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us